MARKER THERAPEUTICS, INC. Related Party Transaction, Expenses from Transactions with Related Party
MARKER THERAPEUTICS, INC. (MRKR) reported Related Party Transaction, Expenses from Transactions with Related Party of $215.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2023-05-15
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2023-03-31 was $215.00K, a 78.75% decline year-over-year.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-12-31 was $93.00K, a 91.23% decline year-over-year.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-09-30 was $71.00K, a 92.22% decline year-over-year.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-06-30 was $331.00K, a 65.34% decline year-over-year.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for fiscal 2022 was $1.51M, a 56.12% decline from fiscal 2021.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for fiscal 2021 was $3.44M, a 69.23% increase from fiscal 2020.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for fiscal 2020 was $2.03M, a 475.35% increase from fiscal 2019.
- MARKER THERAPEUTICS, INC. related party transaction, expenses from transactions with related party for fiscal 2019 was $353.00K, a 155.80% increase from fiscal 2018.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 3 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 12 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $215.00K 10-Q · filed 2023-05-15 | $308.00K derived: sum of 2 quarters · filed 2023-05-15 | $379.00K derived: sum of 3 quarters · filed 2023-05-15 | $710.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $164.00K derived: sum of 2 quarters · filed 2023-03-22 | $495.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.51M 10-K · filed 2023-03-22 | ||||
| 2022-09-30 | $71.00K 10-Q · filed 2022-11-10 | $402.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.42M 10-Q · filed 2022-11-10 | $2.47M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-06-30 | $331.00K 10-Q · filed 2022-08-11 | $1.34M 10-Q · filed 2022-08-11 | $2.40M derived: sum of 3 quarters · filed 2023-05-15 | $3.32M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-03-31 | $1.01M 10-Q · filed 2023-05-15 | $2.07M derived: sum of 2 quarters · filed 2023-05-15 | $2.98M derived: sum of 3 quarters · filed 2023-05-15 | $3.94M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.97M derived: sum of 2 quarters · filed 2023-03-22 | $2.93M derived: sum of 3 quarters · filed 2023-03-22 | $3.44M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $913.00K 10-Q · filed 2022-11-10 | $843.00K 10-Q · filed 2021-11-10 | $1.87M derived: sum of 2 quarters · filed 2022-11-10 | $2.38M 10-Q · filed 2022-11-10 | $2.27M 10-Q · filed 2021-11-10 | $3.54M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $955.00K 10-Q · filed 2022-08-11 | $1.46M 10-Q · filed 2022-08-11 | $1.42M 10-Q · filed 2021-08-10 | $2.62M derived: sum of 3 quarters · filed 2022-08-11 | $3.03M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $502.00K 10-Q · filed 2022-05-13 | $468.00K 10-Q · filed 2021-05-12 | $1.67M derived: sum of 2 quarters · filed 2022-05-13 | $2.07M derived: sum of 3 quarters · filed 2022-05-13 | $2.27M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.57M derived: sum of 2 quarters · filed 2022-03-17 | $1.76M derived: sum of 3 quarters · filed 2022-03-17 | $2.03M 10-K · filed 2022-03-17 | $1.97M 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $405.00K 10-Q · filed 2021-11-10 | $598.00K derived: sum of 2 quarters · filed 2021-11-10 | $864.00K 10-Q · filed 2021-11-10 | $900.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $193.00K 10-Q · filed 2021-08-10 | $447.00K 10-Q · filed 2021-08-10 | $495.00K derived: sum of 3 quarters · filed 2021-08-10 | $572.00K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $255.00K 10-Q · filed 2021-05-12 | $235.00K 10-Q · filed 2020-05-11 | $302.00K derived: sum of 2 quarters · filed 2021-05-12 | $379.00K derived: sum of 3 quarters · filed 2021-05-12 | $491.00K derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $124.00K derived: sum of 2 quarters · filed 2021-03-09 | $236.00K derived: sum of 3 quarters · filed 2021-03-09 | $353.00K 10-K · filed 2021-03-09 | $302.00K 10-K · filed 2020-03-12 | |||
| 2019-09-30 | $77.00K 10-Q · filed 2020-11-09 | $189.00K derived: sum of 2 quarters · filed 2020-11-09 | $306.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $112.00K 10-Q · filed 2020-08-10 | $237.00K 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $88.50K 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | $138.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |